KORLYM

Serial Number 85218444
Registration 4313527
800

Registration Progress

Application Filed
Jan 14, 2011
Under Examination
Jul 26, 2011
Approved for Publication
May 31, 2011
Published for Opposition
May 31, 2011
Registered
Apr 2, 2013

Trademark Image

KORLYM

Basic Information

Serial Number
85218444
Registration Number
4313527
Filing Date
January 14, 2011
Registration Date
April 2, 2013
Published for Opposition
May 31, 2011
Renewal Date
April 2, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
800
Status Date
Sep 27, 2023
Registration
Registered
Classes
005

Rights Holder

Corcept Therapeutics, Inc.

03
Address
149 Commonwealth Drive
Menlo Park, CA 94025

Ownership History

Corcept Therapeutics, Inc.

Original Applicant
03
Menlo Park, CA

Corcept Therapeutics, Inc.

Owner at Publication
03
Menlo Park, CA

Corcept Therapeutics, Inc.

Original Registrant
03
Menlo Park, CA

Legal Representation

Attorney
Joel R. Feldman

USPTO Deadlines

Next Deadline
2814 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2013-04-02)
Due Date
April 02, 2033
Grace Period Ends
October 02, 2033

Application History

41 events
Date Code Type Description Documents
Sep 27, 2023 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Sep 27, 2023 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Sep 27, 2023 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Sep 24, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Mar 20, 2023 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Nov 21, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 21, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 21, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 2, 2022 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Mar 8, 2019 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Mar 8, 2019 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Mar 8, 2019 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jan 30, 2019 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jan 30, 2019 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 2, 2018 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Sep 6, 2017 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Apr 2, 2013 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 26, 2013 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Feb 23, 2013 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED Loading...
Feb 21, 2013 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 28, 2013 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jan 23, 2013 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jan 23, 2013 IUAF S USE AMENDMENT FILED Loading...
Aug 3, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 2, 2012 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 25, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 25, 2012 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 23, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 22, 2012 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 22, 2012 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 26, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 26, 2012 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 26, 2011 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 31, 2011 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 31, 2011 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 26, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Apr 25, 2011 ALIE A ASSIGNED TO LIE Loading...
Apr 11, 2011 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 5, 2011 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 21, 2011 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 18, 2011 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of psychiatric, neurological and endocrine diseases and disorders
First Use Anywhere: Apr 10, 2012
First Use in Commerce: Apr 10, 2012

Classification

International Classes
005